Public procurement notice: Contract Notice
Published: 2018-09-22
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 107012831 GBP
Submission deadline: 2018-10-24
Award criteria: The most economic tender

Technical requirements: The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland:
The Goods have been split into five (5) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section II.2 of this notice.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This Lot is for the supply of Etanercept 10 mg, 25 mg, 50 mg presentations to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.
Each product line will be treated as an individual Lot and will be awarded on a line by line basis. It is envisaged that each Lot will be awarded as an unranked multi supplier Framework to a maximum of three (3) Framework Participants.
The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This Lot is for the supply Infliximab 100 mg powder for concentrate for solution for infusion to NHS Scotland.
This Lot will be treated as unranked multi supplier Framework and it is envisaged it will be awarded to a maximum of five (5) Framework Participants.
The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Lot is for the supply of Methotrexate (50 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.
The Authority intends awarding a multi-supplier unranked Framework Agreement for the Lot and it is envisaged a maximum of three (3) Framework Participants will be awarded. Full details can be found within the ITT.
The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 107012831